SCHEMBL6434585

SCHEMBL6434585

CC(C)(C)[Si](C)(C)O[C@@H](C=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6434593 1.00
SCHEMBL8993490 0.85 FFAR2 (0.35)
SCHEMBL8993485 0.85 FFAR2 (0.35)
SCHEMBL9116402 0.85 FFAR2 (0.35)
SCHEMBL7712823 0.85 ACP3 (0.34)
SCHEMBL4542209 0.85 ACP3 (0.34)
SCHEMBL15229025 0.81 MDM2 (0.36)
SCHEMBL12497813 0.80 SLC6A3 (0.33)
SCHEMBL12497693 0.77 APLNR (0.34)
SCHEMBL8402080 0.77 ATM (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087943-B1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LTD (GB) 2005-08-17 EP disclosed
US-6251925-B1 AN AGONISTS FOR HUMAN BETA-3 ADRENOCEPTOR GLAXO WELLCOME INC. 2001-06-26 US disclosed
EP-1087943-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065877-A1 THERAPEUTIC BIARYL DERIVATIVES GLAXO GROUP LIMITED (GB) 1999-12-23 WO disclosed